Literature DB >> 20369651

The safe treatment, monitoring and management of severe traumatic brain injury patients in a monoplace chamber.

W A Gossett1, G L Rockswold, S B Rockswold, C D Adkinson, T A Bergman, R R Quickel.   

Abstract

This report describes how 27 patients with severe traumatic brain injury were safely treated, monitored and managed in a monoplace chamber that was compressed with air to 1.5 atmospheres absolute (152 kPa). A total of 75 hyperbaric oxygen treatments were delivered using the monoplace system described, with all patients receiving 100% oxygen via mechanical ventilation. Specific pieces of equipment, components and features were selected, and modifications were interfaced to safely and effectively treat these critically ill patients in a monoplace chamber. Patient monitoring included cardiovascular and ventilatory parameters as well as intracranial pressure, brain tissue oxygen levels, brain temperature and cerebral microdialysis. The chamber and all the supporting equipment for ventilating, monitoring and managing the patient functioned well.

Entities:  

Mesh:

Year:  2010        PMID: 20369651

Source DB:  PubMed          Journal:  Undersea Hyperb Med        ISSN: 1066-2936            Impact factor:   0.698


  3 in total

1.  Hyperbaric Oxygen Therapy in the Treatment of Acute Severe Traumatic Brain Injury: A Systematic Review.

Authors:  Samuel Daly; Maxwell Thorpe; Sarah Rockswold; Molly Hubbard; Thomas Bergman; Uzma Samadani; Gaylan Rockswold
Journal:  J Neurotrauma       Date:  2018-01-22       Impact factor: 5.269

Review 2.  Is Hyperbaric Oxygen Therapy Effective for Traumatic Brain Injury? A Rapid Evidence Assessment of the Literature and Recommendations for the Field.

Authors:  Cindy Crawford; Lynn Teo; EunMee Yang; Caitlin Isbister; Kevin Berry
Journal:  J Head Trauma Rehabil       Date:  2017 May/Jun       Impact factor: 2.710

3.  Hyperbaric oxygen therapy improves cognitive functioning after brain injury.

Authors:  Su Liu; Guangyu Shen; Shukun Deng; Xiubin Wang; Qinfeng Wu; Aisong Guo
Journal:  Neural Regen Res       Date:  2013-12-15       Impact factor: 5.135

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.